Search

everythinglearnresearchcommunity

for

Search:↓

Ent-kaurane-type diterpenoids from Isodonis Herba may promote hair growth by boosting cell proliferation.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Finasteride increases CD8+ T cells in BPH tissues.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Reducing SOX2 in colorectal cancer cells decreases tumor growth and self-renewal.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

The method effectively induces skin cancer in mice for studying tumor development.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

Sesn2 protects inner ear hair cells from damage by regulating certain cell survival pathways.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Ruxolitinib can help regrow hair in severe alopecia areata.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.